1. Home
  2. HEPS vs SDGR Comparison

HEPS vs SDGR Comparison

Compare HEPS & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Market Electronic Services & Trading

HEPS

D-Market Electronic Services & Trading

HOLD

Current Price

$2.68

Market Cap

1.0B

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$20.91

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEPS
SDGR
Founded
2000
1990
Country
Turkey
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HEPS
SDGR
Price
$2.68
$20.91
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$3.07
$21.00
AVG Volume (30 Days)
162.6K
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
$41.29
$0.76
Revenue Next Year
$27.99
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$2.15
$10.95
52 Week High
$3.30
$23.02

Technical Indicators

Market Signals
Indicator
HEPS
SDGR
Relative Strength Index (RSI) 46.14 66.44
Support Level $2.52 $17.23
Resistance Level $2.92 N/A
Average True Range (ATR) 0.12 1.00
MACD -0.00 0.10
Stochastic Oscillator 47.75 87.75

Price Performance

Historical Comparison
HEPS
SDGR

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: